| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +100.00% | -5.46% | -0.31% | -5.16% | -4.74% | — |
| 14d | 3 | +66.67% | -8.17% | -0.26% | -7.92% | -6.76% | — |
| 30d | 3 | +66.67% | -11.23% | -3.27% | -7.96% | -8.16% | — |
| 60d | 3 | +100.00% | -11.84% | +5.13% | -16.97% | -20.98% | — |
| 90d | 3 | +100.00% | -7.83% | +9.06% | -7.38% | -7.38% | — |
| 180d | 3(2 pending) | +0.00% | -10.89% | +1.76% | -12.66% | -12.66% | — |
| 1y | 3(2 pending) | +0.00% | -24.58% | +19.74% | -44.32% | -44.32% | — |
| 2y | 3(3 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASE CEO and President | 2,500 | $1.26 | $3.1K | 27,217 | Jun 30, 2026 | Jul 1, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE CEO and President | 7,500 | — | — | 281,930 | Jun 30, 2026 | Jul 1, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE CEO and President | 2,500 | — | — | 118,417 | Jun 30, 2026 | Jul 1, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 10,000 | $16.01 | $160.1K | 17,217 | Jun 30, 2026 | Jul 1, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASE CEO and President | 7,500 | $1.01 | $7.6K | 24,717 | Jun 30, 2026 | Jul 1, 2026 ↗ | View → |
| KPRX KIORA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Jun 10, 2026 | Jun 11, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE CEO and President | 2,700 | — | — | 120,917 | Feb 25, 2026 | Feb 26, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 2,700 | $16.02 | $43.2K | 14,954 | Feb 25, 2026 | Feb 26, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASE CEO and President | 2,700 | $1.26 | $3.4K | 17,654 | Feb 25, 2026 | Feb 26, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASE CEO and President | 4,400 | $1.26 | $5.5K | 19,354 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 4,400 | $16.02 | $70.5K | 14,954 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE CEO and President | 4,400 | — | — | 123,617 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE CEO and President | 400 | — | — | 128,017 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 400 | $16.00 | $6.4K | 14,954 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASE CEO and President | 400 | $1.26 | $504 | 15,354 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 445,000 | — | — | 445,000 | Jan 30, 2026 | Jan 30, 2026 ↗ | View → |
| KPRX KIORA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 20,000 | — | — | 20,000 | Apr 1, 2025 | Apr 2, 2025 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Jan 31, 2025 | Jan 31, 2025 ↗ | View → |
| KPRX KIORA PHARMACEUTICALS INC | PURCHASE | 1,250 | $3.68 | $4.6K | 1,250 | Sep 11, 2024 | Sep 12, 2024 ↗ | View → |
| KPRX KIORA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 1,778 | — | — | 1,778 | Jul 1, 2024 | Jul 3, 2024 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 285,000 | — | — | 285,000 | May 24, 2024 | May 29, 2024 ↗ | View → |
| KPRX KIORA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 8,000 | — | — | 8,000 | Sep 29, 2023 | Oct 3, 2023 ↗ | View → |